急性脑损伤宽松与限制性输血策略:系统评价与频率学派-贝叶斯Meta分析
该系统评价与频率学派-贝叶斯Meta分析纳入4项随机对照试验(N=1853;宽松组922例,限制组931例),比较成人急性脑损伤(颅脑创伤、蛛网膜下腔出血、颅内出血)且格拉斯哥昏迷评分≤13患者宽松输血(≥9 g/dL)与限制性输血(≥7 g/dL)对180天良好神经功能的影响。频率学派合并RR为0.84(95%CI 0.65-1.09;I²=58%),未达统计学显著;预设的低偏倚风险试验敏感性分析提示宽松策略可能获益(RR 0.74,95%CI 0.63-0.87;I²=0%)。贝叶斯分析显示估计效应依赖先验假设,试验序贯分析提示现有证据不足以确认确定性效应,次要结局组间无显著差异。
要点
- 4项RCT(N=1853;宽松922例,限制931例)合并显示宽松输血对180天良好神经功能RR 0.84(95%CI 0.65-1.09;I²=58%),未达统计学显著。
- 预设低偏倚风险试验敏感性分析提示宽松策略可能获益:RR 0.74(95%CI 0.63-0.87),无异质性(I²=0%)。
- 颅脑创伤亚组及按初始格拉斯哥昏迷评分分层的结果与主要分析一致。
- 贝叶斯分析显示估计效应依赖先验假设,来自一项方案独特试验的不利先验可能性低于中性或有利先验。
- 试验序贯分析提示现有证据不足以确认确定性效应,次要结局组间无显著差异。
适用人群与场景
- 成人急性脑损伤患者,包括颅脑创伤、蛛网膜下腔出血、颅内出血,且格拉斯哥昏迷评分≤13。
诊断标准与关键阈值
- 宽松输血策略阈值:血红蛋白≥9 g/dL。
- 限制性输血策略阈值:血红蛋白≥7 g/dL。
研究设计与关键结果
- 研究类型:系统评价与频率学派-贝叶斯Meta分析,纳入4项随机对照试验,共N=1853例(宽松组922例,限制组931例)。
- 主要终点(180天良好神经功能)频率学派合并RR 0.84(95%CI 0.65-1.09;I²=58%)。
- 预设低偏倚风险试验敏感性分析:RR 0.74(95%CI 0.63-0.87),I²=0%。
- 颅脑创伤亚组及按初始格拉斯哥昏迷评分分层的结果与主要分析一致。
- 贝叶斯分析:估计治疗效应取决于所用假设与先验,来自一项方案独特试验的不利先验较中性或有利先验可能性更低。
- 试验序贯分析:现有证据不足以确认确定性效应。
- 次要结局组间无显著差异。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析(含频率学派、贝叶斯及试验序贯分析),纳入4项随机对照试验。
- 局限:频率学派合并结果存在异质性(I²=58%);贝叶斯估计依赖先验假设;试验序贯分析提示证据不足以确认确定性效应;作者指出未来研究应聚焦识别最可能获益的患者亚组以指导个体化策略。
对床旁实践的改变
- 本综述未提供宽松输血策略改善急性脑损伤神经功能的确定性证据,频率学派与贝叶斯分析均强调单项试验对总体效应估计和异质性的影响。
- 敏感性分析排除该试验并聚焦低偏倚风险研究后,提示宽松输血策略可能改善神经功能,作者认为未来研究应识别最可能获益的患者亚组以指导更个体化的策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To determine whether a liberal transfusion strategy (≥ 9 g/dL) improves neurological outcomes in adults with acute brain injury (ABI).
METHOD: We systematically searched MEDLINE, EMBASE, the Cochrane Library, and trial registries for randomized controlled trials comparing liberal (≥ 9 g/dL) vs. restrictive (≥ 7 g/dL) transfusion in adults with ABI (traumatic brain injury, subarachnoid hemorrhage, intracranial hemorrhage) and Glasgow Coma Scale ≤ 13. Frequentist, Bayesian, and trial sequential analyses were used. The primary outcome was favorable neurological status at 180 days.
RESULTS: Four randomized controlled trials (N = 1853; 922 liberal, 931 restrictive) were included. The pooled frequentist risk ratio (RR) for favorable neurological outcome was 0.84 (95% CI 0.65-1.09; I2 = 58%). In a pre-specified sensitivity analysis including only low-risk-of-bias trials, the results suggested a potential benefit in favor of the liberal strategy (RR 0.74 [95% CI 0.63-0.87]) with no heterogeneity (I2 = 0%). Subgroup analyses for patients with traumatic brain injury or stratified by initial Glasgow coma scale were consistent with the main findings. Bayesian analyses showed that the estimated treatment effect depended on the assumptions and priors used, with an unfavorable prior derived from one trial with distinct protocol appearing less likely than neutral or favorable priors. Trial sequential analysis indicated that current evidence is insufficient to confirm a definitive effect. Secondary outcomes did not differ significantly between groups.
CONCLUSIONS: This review did not provide definitive evidence of a neurological benefit from liberal transfusion strategies in acute brain injury. Both frequentist and Bayesian analyses highlight the influence of a single trial on the overall effect estimate and heterogeneity. However, sensitivity analyses excluding this trial and focusing on studies with low risk of bias suggested that liberal transfusion strategies could improve neurological outcomes. Future research should focus on identifying patient subgroups most likely to benefit, guiding a more individualized approach.
参考来源
- Blot PL, Renaux M, Ayasse T, et al. Liberal vs. restrictive transfusion strategies for acute brain injury: a systematic review and frequentist-Bayesian meta-analysis. Intensive Care Med. 2025. PMID: 39961845. doi:10.1007/s00134-025-07807-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。